Metraipolis › archive › dc_7a8d772e49d6

Blood sLOX-1 Is Beneficial for Determining Severity of Neonatal Hypoxic-Ischemic Encephalopathy: A Nationwide Prospective Cohort Study — Europe PMC PMID:42506360

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42506360
DOI
10.3390/medsci14030391
License (as archived)
solo-consultazione
Archived
2026-10-18T07:03:07.859Z
SHA-256 of the archived text
f7077300db12ff78513ab430de2aedfbd084b52cf277ffc7234b546a85d5ff41
Stable URL of this page
https://metraipolis.com/documento/dc_7a8d772e49d6

How to cite

Blood sLOX-1 Is Beneficial for Determining Severity of Neonatal Hypoxic-Ischemic Encephalopathy: A Nationwide Prospective Cohort Study — Europe PMC PMID:42506360 — Europe PMC (en), https://europepmc.org/article/MED/42506360 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7a8d772e49d6 (Metraipolis archive dc_7a8d772e49d6, sha256 f7077300db12ff78513ab430de2aedfbd084b52cf277ffc7234b546a85d5ff41)
BibTeX
@misc{dc7a8d772e49d6,
  title = {Blood sLOX-1 Is Beneficial for Determining Severity of Neonatal Hypoxic-Ischemic Encephalopathy: A Nationwide Prospective Cohort Study — Europe PMC PMID:42506360},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42506360},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7a8d772e49d6; sha256 f7077300db12ff78513ab430de2aedfbd084b52cf277ffc7234b546a85d5ff41},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42506360. Agents can read the archived copy with the MCP tool read_document.